首页> 美国卫生研究院文献>PLoS Clinical Trials >Identification of ABC Transporter Interaction of a Novel Cyanoquinoline Radiotracer and Implications for Tumour Imaging by Positron Emission Tomography
【2h】

Identification of ABC Transporter Interaction of a Novel Cyanoquinoline Radiotracer and Implications for Tumour Imaging by Positron Emission Tomography

机译:新型氰基喹啉放射性示踪剂的ABC转运蛋白相互作用的鉴定及其对正电子发射断层扫描技术在肿瘤成像中的意义

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe epidermal growth factor receptor (EGFR) is overexpressed in many cancers including lung, ovarian, breast, head and neck and brain. Mutation of this receptor has been shown to play a crucial role in the response of non-small cell lung carcinoma (NSCLC) to EGFR-targeted therapies. It is envisaged that imaging of EGFR using positron emission tomography (PET) could aid in selection of patients for treatment with novel inhibitors. We recognised multi-drug resistant phenotype as a threat to development of successful imaging agents. In this report, we describe discovery of a novel cyanoquinoline radiotracer that lacks ABC transporter activity.
机译:背景表皮生长因子受体(EGFR)在许多癌症中过表达,包括肺癌,卵巢癌,乳腺癌,头颈癌和脑癌。该受体的突变已显示在非小细胞肺癌(NSCLC)对EGFR靶向疗法的应答中起关键作用。可以设想,使用正电子发射断层扫描(PET)对EGFR成像可以帮助选择要使用新型抑制剂治疗的患者。我们认识到多药耐药性表型是对成功的成像剂发展的威胁。在此报告中,我们描述了缺乏ABC转运蛋白活性的新型氰基喹啉放射性示踪剂的发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号